Question 1

Does Temasek Holdings (Private) own NTLA stock?

Accepted Answer

No. Temasek Holdings (Private) exited its NTLA (Intellia Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 279,693 shares worth $3.3M.

Question 2

How many shares of NTLA does Temasek Holdings (Private) own?

Accepted Answer

None since Q1 2025, when Temasek Holdings (Private) exited the position. Its Q4 2024 13F listed 279,693 shares worth $3.3M.

Question 3

What is Temasek Holdings (Private)'s NTLA position worth?

Accepted Answer

Temasek Holdings (Private)'s NTLA position was worth $3.3M in its Q4 2024 13F, before the exit in Q1 2025.

Question 4

Is Temasek Holdings (Private) buying or selling NTLA?

Accepted Answer

In Q1 2025, Temasek Holdings (Private) exited its entire NTLA position.

Question 5

When did Temasek Holdings (Private) first buy NTLA?

Accepted Answer

Temasek Holdings (Private) already held NTLA in its Q4 2018 13F, the earliest on record, and listed it in 25 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$7.11
2024-Q4	Unchanged	279,693	0.0%	$3.3M	0.0%	$11.66
2024-Q3	Unchanged	279,693	0.0%	$5.7M	0.0%	$20.55